CHM 10.0% 2.2¢ chimeric therapeutics limited

Ann: CDH17 CAR T PRECLINICAL DATA FEATURED IN NATURE CANCER, page-15

  1. 387 Posts.
    lightbulb Created with Sketch. 76
    Can anyone here mentioning acquisitions just please stop. Like this group is 4 years away from that at minimum. They will develop their assets through to end of phase 2, have a market cap of 1-2billion and only then will they start negotiating with big pharma for a buyout.. Just hold the fkn line and load up while it's cheap lmao
    Last edited by shemara: 23/03/22
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.002(10.0%)
Mkt cap ! $18.39M
Open High Low Value Volume
2.2¢ 2.2¢ 2.0¢ $21.40K 1.025M

Buyers (Bids)

No. Vol. Price($)
5 385342 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 255138 3
View Market Depth
Last trade - 14.29pm 24/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.